Two health announcements landed 48 hours apart last week, and hardly anyone connected them. On Monday, the Emirates Drug Establishment approved a once-daily pill for non-segmental vitiligo, the condition that...
Most-favored-nation drug pricing is usually presented as a clever way to make other countries pay their fair share. Americans pay more for the same medicine than Germans, Canadians or the...
The Consumer Choice Center appreciates the opportunity to respond to the Senate Finance Committee Minority Staff’s Request for Information on lowering prescription drug costs. CCC is a nonpartisan consumer advocacy...
WASHINGTON, D.C. — July 22, 2026 — The Consumer Choice Center (CCC) today warned that the White House’s newly announced tariff schedule on generic medicines will raise costs and undermine...
There’s a quiet rule change working its way through the Centers for Medicare and Medicaid Services (CMS). Most Americans will never hear about it. But it tells you everything about...
Earlier this year, Dr. Mehmet Oz announced from his perch atop the Centers for Medicare and Medicaid Services that eligible Medicare Part D beneficiaries will be able to access select GLP-1 obesity medicines...
Other provinces should follow Alberta’s lead in embracing dual practice in healthcare Toronto, ON: The Consumer Choice Center is calling on other Canadian provinces to follow Alberta’s lead, with the...
A rising young hockey player lost his life just days after Health Canada finally gave the green light to a treatment that might have helped him beat the cancer that...
Congress created the 340B Drug Pricing Program more than 30 years ago with the goal of helping safety-net providers stretch limited resources to expand care for vulnerable patients. Hospitals and...
Heart disease remains one of the biggest health challenges in the world. It is also a major issue in the Gulf. Across the Middle East, cardiovascular disease is the leading...
EU Pharma Reform Should Focus on What Consumers Actually Need: Access, Reliability, and Innovation Brussels, 29 May 2026 – The Consumer Choice Center welcomes the continued progress of the EU...
For patients with needle phobia, the arrival of oral GLP-1 weight-loss medicines is not a shortcut. It is an opening. The UAE’s approval of Foundayo, alongside the availability of oral...
